Pan-cancer analysis indicated that NPLOC4 was highly expressed in most types of cancer, including clear cell renal cell carcinoma, bladder urothelial carcinoma, and papillary renal cell carcinoma (Fig. 1a). Here, NPLOC4 is linked to papillary renal cell carcinoma.